• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET Back to Search Results
Catalog Number 4123201
Device Problems No Apparent Adverse Event (3189); Insufficient Information (3190)
Patient Problem Hypervolemia (2664)
Event Date 08/07/2023
Event Type  malfunction  
Manufacturer Narrative
Investigation: calculate final fluid balance (including saline bolus): 4329 + 574ml (machine fb) + 500 ml bolus = 5403 ml/ 4329 ml= 1.25 * 100 = 125% investigation is in process, a follow-up report will be provided.
 
Event Description
A customer reported to terumo bct customer support that at the beginning of a continuous mononuclear cell collection (cmnc) procedure the optia device alarmed with a notification stating that the hematocrit is too low to establish interface.After the customer assessed the patient and entered the hematocrit value against a point-of-care value to confirm, they continued the run.After roughly 45 minutes into the collection the 500ml saline bag was depleted and the customer replaced the bag with a new one and used hemostats to maintain closure of the saline line and was able to complete the collection without incident.Per follow up with the customer, the roller clamp was failing to securely close the return saline line.The saline roller clamps were on the correct lines and closed properly and no blood was seen in the saline bag.The patient was discharged from the collection center on the day of procedure per protocol and not medical intervention or symptoms were reported.The customer declined to provide the patient id.The collection set is not available for return because it was discarded by the customer.
 
Event Description
A customer reported to terumo bct customer support that at the beginning of a continuous mononuclear cell collection (cmnc) procedure the optia device alarmed with a notification stating that the hematocrit is too low to establish interface.After the customer assessed the patient and entered the hematocrit value against a point-of-care value to confirm, they continued the run.After roughly 45 minutes into the collection the 500ml saline bag was depleted and the customer replaced the bag with a new one and used hemostats to maintain closure of the saline line and was able to complete the collection without incident.Per follow up with the customer, the roller clamp was failing to securely close the return saline line.The saline roller clamps were on the correct lines and closed properly and no blood was seen in the saline bag.The patient was discharged from the collection center on the day of procedure per protocol and not medical intervention or symptoms were reported.The customer declined to provide the patient id.The collection set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
This report is being filed to provide additional information in h.6 and h.10.Investigation: calculate final fluid balance (including saline bolus): 4329 + 574ml (machine fb) + 500 ml bolus = 5403 ml/ 4329 ml= 1.25 * 100 = 125% further evaluation of this event has determined that the device did not cause or contribute to a death or serious injury, nor is there a likely potential for death or serious injury associated with this event based on additional investigational information.Upon further review of this event it was determined that the final fluid balance was below the reportable limit.No further reporting will be provided as this does not represent a reportable event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA IDL SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer (Section G)
TERUMO BCT
10810 w. collins ave
lakewood CO 80215
Manufacturer Contact
scot hilden
10810 w. collins ave
lakewood, CO 80215
MDR Report Key17670704
MDR Text Key322508274
Report Number1722028-2023-00292
Device Sequence Number1
Product Code LKN
UDI-Device Identifier05020583123205
UDI-Public05020583123205
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K183081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number4123201
Device Lot Number2304116141
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/07/2023
Initial Date FDA Received09/01/2023
Supplement Dates Manufacturer Received01/17/2024
Supplement Dates FDA Received01/23/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured04/11/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age40 YR
Patient SexFemale
-
-